Kymera Therapeutics Inc. (KYMR): Price and Financial Metrics
KYMR Price/Volume Stats
| Current price | $47.62 | 52-week high | $53.27 |
| Prev. close | $47.66 | 52-week low | $19.44 |
| Day low | $47.03 | Volume | 985,412 |
| Day high | $49.98 | Avg. volume | 753,776 |
| 50-day MA | $30.50 | Dividend yield | N/A |
| 200-day MA | $39.51 | Market Cap | 3.10B |
KYMR Stock Price Chart Interactive Chart >
Kymera Therapeutics Inc. (KYMR) Company Bio
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; and STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases. The company was founded in 2015 and is headquartered in Watertown, Massachusetts.
KYMR Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
KYMR Price Returns
| 1-mo | 63.59% |
| 3-mo | 44.79% |
| 6-mo | 2.04% |
| 1-year | 44.87% |
| 3-year | 187.56% |
| 5-year | N/A |
| YTD | 18.37% |
| 2024 | 58.01% |
| 2023 | 2.00% |
| 2022 | -60.69% |
| 2021 | 2.40% |
| 2020 | N/A |